NASDAQ: ALNA       Allena Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
1.269   -0.012 (0.94%)  1.241 - 1.29  210,390


Avg Volume (4 weeks):531,036
4 Weeks Range:1.02 - 1.31
4 Weeks Price Volatility (%):
52 Weeks Range:1.02 - 2.78
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Allena Pharmaceuticals Inc is a US-based late-stage clinical biopharmaceutical company. It is developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The company focuses on metabolic disorders which result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and lead to chronic kidney disease (CKD), and end-stage renal disease. Its key product candidates are ALLN-177 which is an oral enzyme therapeutic developing for the treatment of hyperoxaluria, and ALLN-346 is being developed for patients with hyperuricemia and moderate to severe CKD.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2078  4710  630  3492 

Top 10 Active Counters
 AMC 62.896+5.896 
 ALF 5.578+2.168 
 TRCH 5.115+1.535 
 WISH 11.47+0.20 
 OCGN 6.69+0.56 
 DKNG 48.465-2.155 
 SNDL 1.00-0.06 
 TCF 45.180.00 
 CLSD 3.92+0.90 
 UXIN 4.55-0.63